Fresh analysis reveals that people who come off popular weight-loss injections like semaglutide or tirzepatide can put back on lost weight far faster than those who halt traditional diet and exercise programs.
Research printed in a prominent medical journal demonstrates that while overweight individuals frequently drop a large proportion of their total mass while undergoing treatment, the weight is regained at an estimated rate of nearly a kilo each month once they quit.
"Individuals buying these treatments should be cognizant of the potential of fast rebound weight gain when the treatment ends," cautioned researcher Dr. Susan Jebb.
This pace of recovery means a reversion to pre-treatment weight within about 18 months.
Comparing Approaches
The analysis, which examined dozens of trials involving over 9,000 of patients, contrasted the results of GLP-1 agonists with conventional dieting.
Researchers point out that people who lose weight through lifestyle changes alone typically have a more gradual creep back—around 0.1 kg a month—once they finish.
Understanding the Quick Regain
Nutrition scientists propose the mechanism of the injections is key to understanding the heightened rebound.
The injections imitate a body's own chemical called glucagon-like peptide-1, which moderates hunger.
"Long-term administration of GLP-1 levels several times higher than the body's typical production could lead to the system to generate a reduced amount of its own natural GLP-1, and may also lessen sensitivity to its actions," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' leads to appetite is no longer kept in check, making overeating much more probable."
An Ongoing Issue?
Health authorities recommend the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Many experts contend that, given the significant potential of weight regain, the treatment might need to be life-long.
This view is echoed by pharmaceutical companies, who say that the findings "highlight the persistent character of excess weight," comparing it to managing diseases like hypertension.
User Testimonies
Users who have come off the jabs explain a sudden resurgence of cravings.
"It was like a switch flipping and I was suddenly extremely hungry," said an individual.
The struggle is compounded if individuals have not adopted lasting lifestyle or habit modifications during therapy.
Growing Adoption
Survey data indicate that millions of adults in the UK have tried these injections in the last 12 months, with demand remaining high.
- Use is higher among women than males.
- The 40s and 50s demographic shows the greatest level of interest.
- Many access the drugs through private healthcare rather than public health services.
In conclusion, clinicians caution that while the jabs are powerful agents for shedding pounds, they are not a permanent solution and long-term success likely depends on combined behavioural management.
